StockSelector.com
  Research, Select, & Monitor Friday, May 24, 2019 9:11:54 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
ADMA Biologics$4.70   

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

ADMA Biologics has an overall rank of 5966 out of 6961 stocks based on 8 positive rankings and 8 negative rankings.

Positive Rankings
Target Prices
The average analysts' target price is $13.00 for ADMA Biologics using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, ADMA Biologics is ranked 42.
Estimated Revenue Growth
ADMA Biologics rank is 79
Historic Revenue Growth
ADMA Biologics rank is 263
90 Day Gain
ADMA Biologics rank is 352
Low/Rising MACD
The MACD remains negative, but is rising... suggesting a possible near-term correction. Of companies with a negative, but rising MACD, ADMA Biologics is ranked 442.
Low vPut/Call
ADMA Biologics has a low Put/Call ratio of 0.33 on active options expiring within the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, ADMA Biologics is ranked 627.
Low Put/Call
ADMA Biologics has a low Put/Call ratio of 0.44 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, ADMA Biologics is ranked 1140.
Up EPS Surprise
ADMA Biologics beat the consensus earnings estimate when it last reported quarterly earnings.
Negative Rankings
Negative ROE
ADMA Biologics rank is 104
Negative Net Margin
ADMA Biologics rank is 298
Price-to-Book
ADMA Biologics rank is 350
Negative ROA
ADMA Biologics rank is 356
Price-to-Sales
ADMA Biologics rank is 419
Down EPS Surprise
ADMA Biologics missed the consensus earnings estimate when it last reported quarterly earnings.
Debt-to-Equity
ADMA Biologics rank is 993
10 Day Loss
ADMA Biologics rank is 1035







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2019 StockSelector.com. All rights reserved.